Eissa, Maryam A. L.
Lerner, Lane
Abdelfatah, Eihab
Shankar, Nakul
Canner, Joseph K.
Hasan, Nesrin M.
Yaghoobi, Vesal
Huang, Barry
Kerner, Zachary
Takaesu, Felipe
Wolfgang, Christopher
Kwak, Ruby
Ruiz, Michael
Tam, Matthew
Pisanic, Thomas R. II
Iacobuzio-Donahue, Christine A.
Hruban, Ralph H.
He, Jin
Wang, Tza-Huei
Wood, Laura D.
Sharma, Anup
Ahuja, Nita
Funding for this research was provided by:
National Institutes of Health (R01CA185357)
School of Medicine, Johns Hopkins University (JHU T32)
Article History
Received: 7 August 2018
Accepted: 10 March 2019
First Online: 5 April 2019
Ethics approval and consent to participate
: The Institutional Review Boards of Johns Hopkins University approved the present study. In addition, blood samples were collected and analyzed as per institutional IRB protocol (NA00033085).
: Not applicable
: NA has received grant funding from Cepheid and Astex and has served as a consultant to Ethicon. NA has licensed methylation Biomarkers (<i>BNC1</i> and <i>ADAMTS1)</i> to Cepheid <i>Inc</i>. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.